Search - tctmd.com

Displaying 1 - 6 of 6

Sort: Relevancy | Date

TCT 231: Safety of Aspirin-Free Prasugrel Monotherapy After PCI: Pooled Analysis of Three Months Outcomes in 508 Patients From ASET-I and ASET-Japan Trials

Presentation TCT 2024

TCT 231: Safety of Aspirin-Free Prasugrel Monotherapy After PCI: Pooled Analysis of Three Months Outcomes in 508 Patients From ASET-I and ASET-Japan Trials

Presenter: KOTARO MIYASHITA

October 27, 2024

TCT 230: Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk: A Post-Hoc Analysis of the TWILIGHT Trial

Presentation TCT 2024

TCT 230: Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk: A Post-Hoc Analysis of the TWILIGHT Trial

Presenter: Mauro Gitto

October 27, 2024

TCT 6: Aspirin-Free Prasugrel Monotherapy After PCI in Patients With Non-ST Elevation Acute Coronary Syndrome

Presentation TCT 2024

TCT 6: Aspirin-Free Prasugrel Monotherapy After PCI in Patients With Non-ST Elevation Acute Coronary Syndrome

Presenter: KOTARO MIYASHITA

October 27, 2024

TCT 2: Less Bleeding by Omitting Aspirin in Non-ST-Segment Elevation Acute Coronary Syndrome Patients (LEGACY)

Presentation TCT 2024

TCT 2: Less Bleeding by Omitting Aspirin in Non-ST-Segment Elevation Acute Coronary Syndrome Patients (LEGACY)

Presenter: Shabiga Sivanesan

October 27, 2024

TCT 237: Long-Term Clopidogrel vs Aspirin Monotherapy in Stable Coronary Artery Disease Patients With High Ischemic Risk: A Post Hoc Analysis of the HOST-EXAM Extended Study

Presentation TCT 2024

TCT 237: Long-Term Clopidogrel vs Aspirin Monotherapy in Stable Coronary Artery Disease Patients With High Ischemic Risk: A Post Hoc Analysis of the HOST-EXAM Extended Study

Presenter: Jeehoon Kang

October 27, 2024

Aspirin Updates: Abbreviated Aspirin for ACS Patients with AF

Presentation Complex Coronary Cases 2023

Aspirin Updates: Abbreviated Aspirin for ACS Patients with AF

Presenter: Joseph M. Sweeny

June 16, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.